Do the New FDA Guidance Documents Help Improving Performance of Blood Glucose Monitoring Systems Compared With ISO 15197?
- PMID: 28587476
- PMCID: PMC5951049
- DOI: 10.1177/1932296817713220
Do the New FDA Guidance Documents Help Improving Performance of Blood Glucose Monitoring Systems Compared With ISO 15197?
Abstract
Recently, the Food and Drug Administration (FDA) published guidance documents for point-of-care testing (POCT) and over-the-counter (OTC) blood glucose monitoring systems (BGMS). These are expected to improve weaknesses of the already established ISO 15197:2013 standard accuracy evaluation for OTC BGMS; however, the proposed criteria and procedures rather raise new questions. As an example, the OTC guidance stipulates tighter accuracy criteria in the low glycemic range than the POCT guidance for no obvious reason. Furthermore, a clear definition of requirements for the reference method is missing under consideration of the strict accuracy criteria. External surveillance of BGMS after introduction to the market is an issue that is addressed neither in the FDA documents, nor in ISO 15197, but in the Clinical and Laboratory Standards Institute (CLSI) guideline POCT12-A3.
Keywords: CLSI guideline; FDA guidance; ISO 15197; POCT; SMBG; blood glucose monitoring system.
Conflict of interest statement
Figures
References
-
- Food and Drug Administration. Blood glucose monitoring test systems for prescription point-of-care use—guidance for industry and food and drug administration staff. Available at: http://www.fda.gov/downloads/MedicalDevices/DeviceRegulationandGuidance/.... Accessed October 10, 2016.
-
- Food and Drug Administration. Self-monitoring blood glucose test systems for over-the-counter use—guidance for industry and food and drug administration staff. Available at: http://www.fda.gov/downloads/MedicalDevices/DeviceRegulationandGuidance/.... Accessed October 10, 2016.
-
- International Organization for Standardization. In vitro diagnostic test systems—requirements for blood-glucose monitoring systems for self-testing in managing diabetes mellitus. ISO 15197:2013.
-
- Clinical and Laboratory Standards Institute (CLSI). POCT12-A3—Point-of-Care Blood Glucose Testing in Acute and Chronic Care Facilities. 3rd ed. Wayne, PA: Clinical and Laboratory Standards Institute; 2013.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials